Kurt Anker Nielsen
Born: 8 August 1945
Nationality: Danish
Resident: Denmark
Position: Director
___________________________________________________________________
Position with Vestas Wind Systems A/S
Elected to the Board of Directors in April 2006 and re-elected for subsequent terms, most recently in 2012. Term of office expires in 2013.
Mr Nielsen meets the definition of independence as set out by the Danish Corporate Governance Committee and the definition of independence of audit committee members as set out in the Danish Auditors' Act.
Designated by the Board of Directors as chairman of the Audit Committee and meets the Danish Auditors' Act's demand for qualifications within financial accounting.
Shareholding
Increased his holding of Vestas shares in 2011 by 1,200 shares. Shareholding as per 31 December 2011: 7,450.
Competencies
| Education: | ||
| 1972 | MSc (Economics and Business Administration), Copenhagen Business School (Denmark) | |
| Former positions: | ||
| 1972–1973 | Business Economist, Carlsberg A/S (Denmark) | |
| 1973–1974 | Management Consultant, Booz, Allen and Hamilton of Scandinavia (Denmark) | |
| 1974–1977 | Economist, Novo Industri A/S (Denmark) | |
| 1977–1984 | Head of Corporate Planning, Novo Industri A/S (Denmark) | |
| 1984–1985 | Director, Corporate Planning and Communications, Novo Industri A/S (Denmark) | |
| 1985–1989 | Vice President Corporate Finance, Novo Industri A/S (Denmark) | |
| 1989–2000 | Chief Financial Officer, Novo Nordisk A/S (Denmark) | |
| 1996–2000 | Deputy CEO, Novo Nordisk A/S (Denmark) | |
| 2000–2003 | CEO, Novo A/S (Denmark) | |
Special competencies
Mr Nielsen has the following special competencies which are essential to the work of the Board of Directors of Vestas Wind Systems A/S: In-depth knowledge of accounting, finance, capital markets and other financial matters as well as experience of managing an international, listed group.
Fiduciary positions
Chairman of the Board of: Dalhoff Larsen & Horneman A/S (Denmark).
Deputy Chairman of the Board of: Novozymes A/S (Denmark).
Member of the Boards of: Novo Nordisk A/S (Denmark), Novo Nordisk Fonden (Denmark) and Veloxis Pharmaceuticals A/S (Denmark).
Positions of trust
Chairman of: Novozymes A/S’ Audit Committee (Denmark) and Veloxis Pharmaceuticals A/S’ Audit Committee (Denmark).
Member of: Novo Nordisk A/S’ Audit Committee (Denmark)
